Results 311 to 320 of about 37,693 (353)
Some of the next articles are maybe not open access.

Diabetes and nephropathy

Current Opinion in Internal Medicine, 2003
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire   +2 more sources

Proteomics and Diabetic Nephropathy

Seminars in Nephrology, 2005
Diabetes mellitus is acknowledged to be a group of metabolic diseases and heterogeneous in natural history, pathogenesis, response to treatment, and disease progression and remission. Diabetic nephropathy (DN) accounts for approximately 40% of all newly diagnosed cases of end-stage renal disease.
Michael L, Merchant, Jon B, Klein
openaire   +3 more sources

Diabetic Nephropathy and Pregnancy

Clinical Obstetrics and Gynecology, 1991
Knowledge of the pathogenic mechanisms of diabetic nephropathy (by which hyperglycemia, hyperfiltration, and hypertension cause the gradual development of microproteinuria, mesangial expansion, and eventual glomerular closure) provides the basis for effective treatment.
C A, Combs, J L, Kitzmiller
openaire   +3 more sources

Nephropathy in Diabetes

2012
The most common cause of end stage renal disease (ESRD) requiring dialysis is diabetes. Both environmental and genetic factors have been postulated as the risk factors of Diabetic Nephropathy (DN). Hyperglycemia-induced metabolic and hemodynamic pathways are recognized to be mediators of kidney injury. Multiple biochemical pathways have been postulated
openaire   +2 more sources

Diabetic Nephropathy

Archives of Internal Medicine, 1990
The discovery and isolation of insulin earlier in this century proved a life-saving advance for many diabetics. But with this treatment new challenges emerged—the progressive systemic microvascular and macrovascular injuries that limit both the quality and duration of life of these patients.
openaire   +2 more sources

Diabetic nephropathy

British Medical Bulletin, 1989
P L, Drury   +3 more
openaire   +2 more sources

Nephropathy in Diabetes

Experimental and Clinical Endocrinology & Diabetes, 2023
Ludwig, Merker   +3 more
openaire   +2 more sources

The Crystalline Nephropathies

Kidney International Reports, 2021
Mark A Perazella, Leal C Herlitz
exaly  

DIABETIC NEPHROPATHY

The American Journal of the Medical Sciences, 1949
openaire   +2 more sources

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies

Advanced Science, 2020
Shrikant R Mulay   +2 more
exaly  

Home - About - Disclaimer - Privacy